# V1 Empirics Check — google/gemini-3-flash-preview (Variant B)

**Model:** google/gemini-3-flash-preview
**Variant:** B
**Date:** 2026-03-31T10:10:03.807144

---

**Referee Report**

**Title:** The Supervision Illusion: Why Removing Physician Oversight of Nurse Anesthetists Did Not Reshape Ambulatory Health Care Labor Markets
**Paper ID:** idea_1792

---

### 1. Idea Fidelity
The paper maintains high fidelity to the original idea manifest. It correctly identifies the staggered nature of the CMS opt-out provision (2001–2022) and utilizes the proposed data source (QWI state-level panel by education and NAICS). The research question remains focused on the restructuring of ambulatory labor markets. The empirical strategy successfully implements the suggested Modern DiD estimators (Callaway-Sant’Anna and Sun-Abraham) and the triple-difference (DDD) approach using hospitals as a control. The placebo tests—both for education (non-BA) and industry (nursing care)—align perfectly with the original identification plan.

### 2. Summary
This paper investigates whether state-level opt-outs from federal physician supervision requirements for Certified Registered Nurse Anesthetists (CRNAs) expanded employment in ambulatory care settings. Utilizing a staggered difference-in-differences design with QWI data (1998–2023), the author finds precisely estimated null effects on BA+ employment in ambulatory settings across multiple robust estimators. The study concludes that the federal supervision mandate was likely non-binding, superseded by informal institutional constraints such as hospital bylaws and payer contracts.

### 3. Essential Points
1.  **Measurement Error in the Treatment Group (Education Variable):** The use of the "BA+" (E4) education group in QWI is a double-edged sword. While it captures CRNAs, it also includes Physicians (MDs), Nurse Practitioners (NPs), and Physician Assistants (PAs). If the policy led to a substitution of CRNAs for MDs (e.g., an ASC hires one CRNA and lets go of one supervising Anesthesiologist), the total BA+ count remains unchanged, resulting in a "null" effect that masks significant labor reallocation. The author must address whether QWI can be complemented with more granular data (e.g., NPPES or ACS) to separate CRNAs from other BA+ professionals.
2.  **State-wide vs. Facility-level Variation:** The CMS opt-out applies to Medicare Conditions of Participation for *facilities*. However, the QWI measures employment at the *state-industry* level. In states like California or Colorado (large, diverse), the "average" effect might be zero while the marginal effect in rural, critical-access hospitals—where the policy was intended to have the most impact—is positive. The author should attempt a sub-group analysis focusing on "Rural" vs. "Urban" counties to see if the "Illusion" persists in areas with acute physician shortages.
3.  **Clarity on State Law vs. Federal Opt-out:** The paper acknowledges that opt-out must be "consistent with state law." This implies that some states might have had restrictive state-level statutes that remained in place even after a CMS opt-out. Without a characterization of the underlying state-level Nurse Practice Acts or medical board regulations, it is unclear if "Treatment" (the CMS opt-out) was actually a legal change in all 22 states or merely a symbolic one.

### 4. Suggestions

*   **Mechanisms of the "Illusion":** The discussion of *ex-post* ratification vs. *ex-ante* constraint (Section 6) is the most compelling part of the paper. I suggest the author expand on the "Payer Contract" hypothesis. If major private insurers (e.g., Blue Cross) still require supervision for reimbursement, the Medicare opt-out is functionally irrelevant for the facility's bottom line. A check of historical Medicaid reimbursement policies for CRNAs in these states would add significant weight.
*   **Event Study Visualization:** While the text mentions that the Callaway-Sant'Anna event study shows clean pre-trends, the paper would be significantly strengthened by the inclusion of the event study plot. This is standard for *AER: Insights* and helps the reader assess the timing of any (even insignificant) divergence.
*   **Earnings Analysis:** The suggestive positive effect on earnings (Table 3, Col 4: 0.136, $p=0.11$) is intriguing. While employment didn't move, a ~14% increase in earnings for BA+ workers in opt-out states suggests increased bargaining power or a shift in the "task mix" (nurses doing more complex, higher-compensated work). This result deserves more than a passing mention; it might suggest the policy isn't an "illusion" for workers' pockets even if it is for firm hiring.
*   **Border-Pair Analysis:** The manifest mentioned a "County-level border-pair design (348,624 county-quarter obs)." This is a powerful way to control for local economic shocks. If the author has these results, including them as a robustness check (showing that a CRNA in an opt-out county doesn't see higher employment than their neighbor across the state line) would be a "knockout" blow to the argument that the regulation is binding.
*   **The "Why It's Larger" Context:** The paper mentions the 2030 nursing shortage. It would be beneficial to link the results to the "cost of care." If opt-out doesn't increase supply, does it at least lower the cost of anesthesia delivery by allowing cheaper labor to be used for the same tasks? Even if employment counts are flat, the total "bill" for anesthesia might change.
*   **Comparison to NP Literature:** The author notes that NP scope-of-practice (SOP) laws *do* have effects. Why is anesthesia different? Is it the presence of the "Anesthesia Care Team" model, which is much more rigid than the "Collaborative Agreement" model used for NPs? A paragraph explicitly contrasting the clinical workflow of a CRNA vs. an NP would clarify why the "Illusion" is specific to this field.
*   **Alternative Controls:** In Table 4, the author uses "never-treated" vs. "not-yet-treated." Given the long time horizon (1998–2023), the "never-treated" group (TX, FL, NY, etc.) are very different from the early adopters (IA, NE, ID). The author might consider a "synthetic control" or a propensity-score-weighted DiD to ensure the controls are more comparable to the (mostly rural) treated states.
